02-17-2008, 01:47 PM
Several hospitals are participating in a study to test the efficacy of a newly developed drug prior to its release.
This drug is designed to lower cholesterol levels. Of the one thousand patients that are involved in this study,
half of the participants receive the drug and half receive a placebo. Neither the physicians in charge of the study
nor the patients are permitted to know what the patients have received. Which of the following steps in the drug
development process does this scenario most closely describe?
A. Investigational New Drug (IND) Application
B. New Drug Application (NDA)
C. Phase I
D. Phase II
E. Phase III
F. Phase IV
This drug is designed to lower cholesterol levels. Of the one thousand patients that are involved in this study,
half of the participants receive the drug and half receive a placebo. Neither the physicians in charge of the study
nor the patients are permitted to know what the patients have received. Which of the following steps in the drug
development process does this scenario most closely describe?
A. Investigational New Drug (IND) Application
B. New Drug Application (NDA)
C. Phase I
D. Phase II
E. Phase III
F. Phase IV